administration of the tiger nut meal showed positive trend in the amelioration of benign prostate hyperplasia by significantly reducing the increased level of the PSA which is biomarker for prostate
this case, control study 150 prostate cancer patients and 150 ages matched benign prostate hyperplasia (BPH) and equal numbers of healthy control groups were involved. The aim of this study ... analyze the effect of…
with PCa. In this study, a total of 113 patients with PCa and benign prostate hyperplasia (BPH) who were treated in our hospital were analyzed retrospectively. The expression of PAK1 ... prostate cancer and benign…
Arif T, Omer A, Ahmed O. MDA as a bio-marker for benign prostatic hyperplasia in Pakistani population. Global Journal of Cancer Case Reports 2019;1(1):1-6 Arif ... Razak S. Evaluation of correlation between expression…
prostate (TURP) is regarded as the gold standard in surgical treatment of benign prostatic hyperplasia (BPH) because of its immediate and enduring effi cacy. However, problems that have ... bleeding. For this reason…
matched with controls. Eighty paraffin embedded tissue samples (40 prostate tissues and 40 benign prostate hyperplasia (BPH) were included. After DNA extraction, polymerase chain reaction method using HPV L1 specific…
designed a case-control study, in which 50 prostate cancer cases and 45 benign prostate hyperplasia cases were studied for GSTP1 Ile105Val polymorphism, compared to 80 controls taken from ... among prostate cancer…
treatment for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), benign prostatic hyperplasia (BPH) and kidney stone disease. The significant improvement in the quality of life of patients has also ... with…
Prostate (TURP) and, 30 formalin-fixed, paraffin embedded blocks were obtained from benign prostatic hyperplasia (BPH) collected from archives of laboratory in Ghazi Al-Hariri hospital for surgical specialties…
emerging including, treatment of pulmonary arterial hypertension, congestive heart failure, Raynaud’s disease, benign prostatic hyperplasia, enhancement of cognitive functions, enhancement of hearing, as well as…
anti-inflammatory drug which is used in the treatment of androgenic alopecia and benign prostatic hyperplasia. The ethosomal formulations were developed using different concentrations of ethanol (20-50%) and soya…
disorder.We report a case of reemergence of urinary incontinence in a patient with benign prostate hyperplasia (BPH) after initiating treatment with venlafaxine, who was stabilized on tamsulosin and finasteride…
Background: Benign prostatic hyperplasia (BPH) is a disorder that is manifested as a non-malignant enlargement of the prostate gland and caused by the progressive hyperplasia of prostatic cells
influence of partial androgen deficiency in aging men (PADAM) on the development of benign prostatic hyperplasia and prostate cancer. American Research Journal of Urology
influence of partial androgen deficiency in aging men (PADAM) on the development of benign prostatic hyperplasia and prostate cancer. American Research Journal of Urology
diagnosis and prognosis of prostate cancer and other conditions such as BPH (benign prostatic hyperplasia) and prostatitis. It is produced by the prostate's columnar epithelium. PSA is a member
differentiation of androgen-dependent cells and increases the risk for development of benign prostatic hyperplasia and prostate cancer. The recovery of testosterone production and regeneration helps make a decrease…
such use? Our work has shown oxytocin to be implicated in both benign prostatic hyperplasia and prostate cancer. In both diseases oxytocin stimulates local steroidogenesis, whilst ithas been shown
organ which has a number of diseases associated with it, such as prostatitis, benign prostatic hyperplasia (BPH), and prostatic cancer (PC). BPH is the most common neoplasm, and it causes
provide a side effects free treatment for common chronic urological diseases, such as benign prostatic hyperplasia (BPH), chronic prostatitis and kidney stone disease. TT and DATD received US patent
provide a side effects free treatment for common chronic urological diseases, such as benign prostatic hyperplasia (BPH), chronic prostatitis and kidney stone disease. TT and DATD received a US patent
research aims to identify proteins in the urinary proteomes of normal controls, benign prostate hyperplasia (BPH) and prostate cancer by initial separation using SDS-PAGE followed by nanoLC-Orbitrap
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.